Sonographic Evaluation of Patients With Carpal Tunnel Syndrome Following Steroid Injection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study was to assess sonographic changes of the median nerve after steroid injection for carpal tunnel syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Corticosteroid Injection in Carpal Tunnel Syndrome

NCT03072290

Carpal Tunnel Syndrome

COMPLETED NA

Comparison of Ultrasound-guided Corticosteroid Injection Versus Corticosteroid Injection and Hydrodissection for Carpal Tunnel Syndrome

NCT04346030

Carpal Tunnel Syndrome

UNKNOWN NA

Median Nerve Injury in US-guided Carpal Tunnel Injections

NCT03391336

Injury of Median Nerve Distal to Forearm Carpal Tunnel Syndrome

COMPLETED

Carpal Tunnel Syndrome - Randomized Clinical Trial Evaluating Effectiveness of Ultrasound in Corticosteroid Injection

NCT02036125

Carpal Tunnel Syndrome

UNKNOWN NA

Effect of Ultrasound-guided Corticosteroid Injection Versus Palpation-guided Injection for de Quervain's Disease

NCT04260984

De Quervain Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with CTS were recruited. The Boston Questionnaire (BQ) was administered and ultrasonographic and electrophysiological examinations were performed before and at two, six, and 12 weeks after steroid injection. Cross sectional area (CSA) was measured at 2 levels: at the tunnel inlet and in the mid-carpal tunnel. Flattening ratio (FR) was measured only in the mid-carpal tunnel. Correlation analyses between baseline ultrasonography, BQ, and electrophysiological measures were performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All patients received steroid injection for carpel tunnel syndrome (CTS) and ultrasonographic evaluation before and after steroid injection

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

steroid injection

ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide

Group Type EXPERIMENTAL

steroid injection

Intervention Type DRUG

ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

steroid injection

ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

triamcinolone acetonide

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. clinical diagnosis of CTS
2. The diagnosis of CTS was confirmed by electrophysiological tests.

Exclusion Criteria

1. neurologic disorders that could mimic CTS such as cervical radiculopathy, polyneuropathy, proximal median nerve entrapment, or thoracic outlet syndrome
2. history of distal radius fracture
3. pregnancy or lactation
4. regular use of systemic NSAIDs or corticosteroids
5. known allergy to corticosteroids and local anesthetics.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No